CHANGE OF THE NUMBER OF SHARES AND VOTES IN KARO BIO

STOCKHOLM, November 4, 2015 - Karo Bio AB (publ) today announced that the company’s total number of shares as per October 31, 2015 amounted to 49 544 121 shares, corresponding to an equal number of votes. The increase in the number of shares and votes results from the recently completed acquisition of 100% of the shares in Swereco Group and the directed new share issue of 2 551 218 shares to the shareholders in Swereco Group.

FOR FURTHER INFORMATION PLEASE CONTACT:
Henrik Palm, CFO, phone 070-540 40 14 or e-mail henrik.palm@karobio.se

ABOUT KARO BIO
Karo Bio is a healthcare company that develops and markets products to pharmacies and directly to healthcare providers. The share is listed on Nasdaq Stockholm.

The information in this report is such that Karo Bio is required to disclose under the Swedish Securities Market Act. The information was disclosed on November 4, 2015 at 7.15 p.m. CET.

This press release is also available on www.karobio.se and www.newsroom.cision.com .

Tags:

About Us

Karo Pharma is a specialty pharma company that develops and markets products to pharmacies and directly to healthcare providers. The share is listed on Nasdaq Stockholm in the Mid Cap segment.

Subscribe

Documents & Links